Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Nagao

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|March 15, 2018
Out-of-hospital cardiac arrest: in-hospital intervention strategiesChristian Hassager, Ken Nagao, David Hildick-Smith
International Heart Journal|April 24, 2015
Association of Fish Consumption-Derived Ratio of Serum n-3 to n-6 Polyunsaturated Fatty Acids and Cardiovascular Risk With the Prevalence of Coronary Artery DiseaseShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
Resuscitation|May 19, 2009
Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitationTakeo Mukoyama, Kosaku Kinoshita, Ken Nagao, et al.
Coronary Artery Disease|March 12, 2011
Association of the serum apolipoprotein levels with the occurrence of coronary vasospasmShigemasa Tani, Ken Nagao, Tsuyoshi Kawamorita, et al.
Heart and Vessels|July 27, 2014
Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatinShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
The American Journal of Cardiology|February 1, 2015
Effect of dipeptidyl peptidase-4 inhibitor, vildagliptin on plasminogen activator inhibitor-1 in patients with diabetes mellitusShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
Heart and Vessels|April 21, 2015
Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional studyShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2005
Relationship between heart-type fatty acid-binding protein levels and the risk of death in patients with serious condition on arrival at the emergency departmentKiyoshi Iida, Ken Nagao, Takahisa Uchiyama, et al.
Journal of Cardiology|September 11, 2013
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle sizeShigemasa Tani, Michiaki Matsumoto, Ken Nagao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 2, 2013
Highly purified eicosapentaenoic acid may increase low-density lipoprotein particle size by improving triglyceride metabolism in patients with hypertriglyceridemiaShigemasa Tani, Ken Nagao, Michiaki Matsumoto, et al.
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|March 15, 2018
Out-of-hospital cardiac arrest: in-hospital intervention strategiesChristian Hassager, Ken Nagao, David Hildick-Smith
International Heart Journal|April 24, 2015
Association of Fish Consumption-Derived Ratio of Serum n-3 to n-6 Polyunsaturated Fatty Acids and Cardiovascular Risk With the Prevalence of Coronary Artery DiseaseShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
Resuscitation|May 19, 2009
Reduced effectiveness of vasopressin in repeated doses for patients undergoing prolonged cardiopulmonary resuscitationTakeo Mukoyama, Kosaku Kinoshita, Ken Nagao, et al.
Coronary Artery Disease|March 12, 2011
Association of the serum apolipoprotein levels with the occurrence of coronary vasospasmShigemasa Tani, Ken Nagao, Tsuyoshi Kawamorita, et al.
Heart and Vessels|July 27, 2014
Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins: comparative study of pitavastatin and atorvastatinShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
The American Journal of Cardiology|February 1, 2015
Effect of dipeptidyl peptidase-4 inhibitor, vildagliptin on plasminogen activator inhibitor-1 in patients with diabetes mellitusShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
Heart and Vessels|April 21, 2015
Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional studyShigemasa Tani, Atsuhiko Takahashi, Ken Nagao, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2005
Relationship between heart-type fatty acid-binding protein levels and the risk of death in patients with serious condition on arrival at the emergency departmentKiyoshi Iida, Ken Nagao, Takahisa Uchiyama, et al.
Journal of Cardiology|September 11, 2013
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle sizeShigemasa Tani, Michiaki Matsumoto, Ken Nagao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 2, 2013
Highly purified eicosapentaenoic acid may increase low-density lipoprotein particle size by improving triglyceride metabolism in patients with hypertriglyceridemiaShigemasa Tani, Ken Nagao, Michiaki Matsumoto, et al.
Pageof 21